Insulin (Human) (recombinant)

by Biosynth


  • CYT-270-250mg | IntroductionInsulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.DescriptionInsulin Human Rec
  • CYT-270-250mg | IntroductionInsulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.DescriptionInsulin Human Rec
Average lead time: Call for Lead Time
ADD TO CART
Need Assistance?

Jump to Section
Product Description
Specifications
Inventory Number:
LVTCYT270250MGEA
Part Number:
CYT-270-250mg
Supplier:
Biosynth
Supplier's Lead Time:
Call for Lead Time
Quantity:
1 per EA
Contract Availability:
GSA
Country of Origin:
United States
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source
ISO 9001:2015 Certified
Copyright 2024, Government Scientific Source. All Rights Reserved.